Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0EAT9 | ISIN: BE0003818359 | Ticker-Symbol: GXE
Tradegate
06.06.25 | 13:29
24,420 Euro
-1,05 % -0,260
Branche
Biotechnologie
Aktienmarkt
BEL Mid
AMX
1-Jahres-Chart
GALAPAGOS NV Chart 1 Jahr
5-Tage-Chart
GALAPAGOS NV 5-Tage-Chart
RealtimeGeldBriefZeit
24,82024,86017:18
24,84024,88017:17

Aktuelle News zur GALAPAGOS NV Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
28.05.GALAPAGOS NV - 6-K, Report of foreign issuer9
GALAPAGOS NV Aktie jetzt für 0€ handeln
27.05.Galapagos NV: Galapagos Creates New Subscription Right Plan513Mechelen, Belgium; May 27, 2025, 22:30 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 925,000 subscription rights under a new...
► Artikel lesen
14.05.Galapagos NV: Galapagos Announces Oral Presentations at EHA and ICML 2025 Featuring Promising New Data from ATALANTA-1 study of Investigational CAR-T Candidate GLPG5101462Mechelen, Belgium; May 14, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation...
► Artikel lesen
13.05.Galapagos stock holds as CEO change, spinoff plans halted15
13.05.Galapagos Says 'No' to SpinCo and Instead Will Seek Deals for All Assets15
13.05.Galapagos backtracks on planned split1
13.05.Galapagos to reevaluate spinoff plans; names new CEO5
13.05.Galapagos gets cold feet over plans to split up company2
13.05.Galapagos drops plan to split after 'market developments'-
13.05.GALAPAGOS NV - 6-K, Report of foreign issuer2
13.05.Galapagos stoppt Unternehmensaufspaltung und prüft strategische Alternativen9
13.05.Galapagos halts corporate separation, explores strategic alternatives; shares rise3
13.05.Galapagos To Re-evaluate Separation Plan, To Explore Alternatives For Existing Businesses; Names CEO7
13.05.Galapagos NV: Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes399Galapagos to re-evaluate the implementation of the previously announced separation following regulatory and market developments Galapagos to explore all strategic alternatives for its existing businesses...
► Artikel lesen
24.04.Galapagos stock holds Market Perform rating at Raymond James14
24.04.Galapagos NV outlines plans for pivotal CAR-T trials and SpinCo separation in 20254
23.04.GALAPAGOS NV - 6-K, Report of foreign issuer2
23.04.Galapagos NV: Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts541First U.S. patient dosed in ATALANTA-1 study of GLPG5101 Mantle cell lymphoma (MCL), a high-unmet-need hematological malignancy, selected as lead indication for the GLPG5101 program; Pivotal development...
► Artikel lesen
23.04.Galapagos GAAP EPS of -€2.35, revenue of €75M2
23.04.Galapagos Appoints Founding CEO of Newly Created SpinCo19
Weiter >>
70 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1